Category: Archive

This category can only be viewed by members. To view this category, sign up by purchasing Monthly Subscription or Annual Subscription.
Posted on by

A de-SPAC to Dodge

G Squared Equity Management L.P. is an investment adviser whose affiliates have sponsored two SPACs: G Squared Ascend I Inc. (NYSE:GSQD) and G Squared Ascend II Inc. (NYSE:GSQB). In dual IPOs last year, the blank-check companies raised $300,000,000 and $125,000,000, respectively, on the promise that their shared management team–which also manages G Squared Equity Management–would […]
To access this post, you must purchase a subscription.
Posted on by

Arcadia Biosciences Rises on Wheat Hype

Just a month ago, Arcadia Biosciences, Inc. (NASDAQ:RKDA) was a penny stock in danger of delisting. But over the past three weeks, the stock has delivered a series of one-day gains as high as 31%. Today, it closed up 34% at $2.62 per share, its highest price since last July. What’s driving the rally? Maybe […]
To access this post, you must purchase a subscription.
Posted on by

Someone Is Smoking INDO

News of a potential ban on Russian oil in the U.S. on Monday led to a rally in nearly every small-cap stock remotely related to oil. The darling of the bunch was Indonesia Energy Corporation Ltd. (NYSEAMERICAN: INDO), which is the latest battleground stock of self-styled retail apes. A month ago, it was hovering around $4.30 per share. Yesterday, it closed at $61.50. Here's why it won't cruise at that altitude for long.
To access this post, you must purchase a subscription.
Posted on by

Mysterious Price Action in Shares of Datasea, Inc.

Last month around Valentine's Day, someone fell in love with Datasea, Inc. (NASDAQ:DTSS). The company's stock price, which had been declining since Jul. 2021, suddenly sprang to life on Feb. 10, 2022. Over the following 12 days, the price rose 81% to $2.64 per share.
To access this post, you must purchase a subscription.
Posted on by

BIMI International Medical, Inc. Is in a Death Spiral

A stock priced at $1.73 per share doesn’t often make an attractive short sale. When it does, the price is usually headed toward zero. Such is the case, in our opinion, with shares of BIMI International Medical, Inc. (NASDAQ:BIMI). We believe the company has entered a classic death spiral.
To access this post, you must purchase a subscription.